600420 Shanghai Shyndec Pharmaceutical
- 10.40
- -0.04-0.38%
Shanghai Shyndec Pharmaceutical News
Announcement on the 2024 Mid-Term Profit Distribution Plan
Announcement on the Listing and Trading of Restricted Shares for Non-public Issuance.
Announcement of the implementation of equity distribution in 2023.
Announcement on the 2023 Profit Distribution Plan
Announcement on the completion of the implementation of the plan for senior management to increase the company\'s shares
Notice on Senior Executives\' Plans to Increase Company Shares
2022 Equity Distribution Implementation Notice
Prompt announcement on passive dilution of shareholders\' shares and changes in equity
Prompt announcement on passive dilution of shareholders\' shares and changes in equity
Prompt announcement on passive dilution of shareholders\' shares and changes in equity
Prompt announcement on passive dilution of shareholders\' shares and changes in equity
Announcement on the implementation results of the plan for directors, supervisors and senior management to increase the company's shares
Announcement on the 2022 profit distribution plan
Announcement on the results of the issuance of non-public shares and changes in share capital
Legal opinion of Guohao Law Firm (Beijing) on the issuance process of Sinopharm Hyundai's non-public offering of A-shares and the compliance of subscribers
Report of CITIC Securities Co., Ltd. on the issuance process of Sinopharm Hyundai's non-public offering of shares and the compliance of subscribers
Indicative announcement on the issuance of non-public shares
Report on the issuance of non-public offering of A-shares
Notice on the application for the non-public offering of shares approved by the China Securities Regulatory Commission
Notice on the revision of the “2022 Plan for Non-public Issuance of A-Shares (Revised Draft)”
Analysis
Price Target
No Data
